Safety and application of laparoscopic gastrectomy for benign gastric disease and gastric cancer.
BACKGROUND
Laparoscopic gastrectomy is rapidly expanding despite reservations by some surgeons regarding its safety and radicality. The aim of this study was to evaluate patients undergoing laparoscopic gastrectomy for both benign and malignant disease with particular emphasis on technical feasibility, safety, effectiveness and complications.


METHODS
Review of prospectively collected data of patients who underwent laparoscopic gastrectomy from May 2005 to September 2009 under the care of one consultant surgeon.


RESULTS
A total of 61 laparoscopic gastrectomies were performed (35 men and 26 women) with a median age of 68 years (range, 41-90 years). There were 39 distal gastrectomies (19 adenocarcinoma, 6 gastrointestinal stromal tumour [GIST], 4 benign gastric outlet obstruction, 4 high-grade dysplasia in gastric adenomas, 4 non-healing ulcers, 2 gastric antral vascular ectasia [GAVE]); 15 sub-total gastrectomies (13 adenocarcinomas, 2 GIST); and 7 total gastrectomies (5 adenocarcinomas, 1 GIST, 1 carcinoid). Median follow-up was for 48 months (range, 1-72 months). There was one death, two major and six minor complications. All patients with complications made a satisfactory recovery.


CONCLUSIONS
Laparoscopic gastrectomy is associated with a low mortality (1.75%) and major morbidity (3.50%). Although technically demanding, especially when a D2 lymphadenectomy is performed, our results have shown that tailored laparoscopic resection based on tumour characteristics with either D1 or D2 lymphadenectomy results in good surgical and oncological outcomes.
Zia
M K
MK
Department of General Surgery, Princess of Wales Hospital, Bridgend, UK.
Morris-Stiff
G
G
Luhmann
A
A
Jeffries
R
R
Ehsan
O
O
Hassn
A
A
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D005240:Feasibility Studies; D005260:Female; D005743:Gastrectomy / Q000009:adverse effects / Q000379:methods*; D006801:Humans; D010535:Laparoscopy; D008197:Lymph Node Excision; D008207:Lymphatic Metastasis; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D013272:Stomach Diseases / Q000601:surgery*; D013274:Stomach Neoplasms / Q000601:surgery; D016896:Treatment Outcome
Ann Surg. 1999 Jan;229(1):49-54
9923799
Adv Surg. 1999;33:69-93
10572562
Surgery. 2010 Apr;147(4):516-20
20004449
Br J Surg. 2001 Oct;88(10):1296-306
11578282
Lancet. 1996 Apr 13;347(9007):995-9
8606613
Br J Surg. 2009 Dec;96(12):1437-42
19918857
Br J Surg. 1990 Dec;77(12):1330-4
2276010
Surg Endosc. 2001 Sep;15(9):928-31
11605108
Br J Surg. 1986 Jul;73(7):513-4
3730782
Surg Endosc. 1992 May-Jun;6(3):160
1386948
World J Gastrointest Surg. 2009 Nov 30;1(1):56-8
21160796
Ann Surg. 2005 Feb;241(2):232-7
15650632
Surg Oncol Clin N Am. 2001 Jul;10(3):655-77
11685934
Surg Endosc. 1997 Jun;11(6):650-2
9171126
Surg Endosc. 2003 Jun;17(6):968-71
12658427
Am J Surg. 2006 Dec;192(6):837-42
17161104
Br J Surg. 1995 Jul;82(7):867-9
7648094
Lancet. 1995 Mar 25;345(8952):745-8
7891484
Surgery. 2002 Jan;131(1 Suppl):S306-11
11821829
Cancer. 1989 Nov 15;64(10):2053-62
2680049
Br J Surg. 1997 Nov;84(11):1567-71
9393281
Br J Surg. 2001 Jan;88(1):128-32
11136325
J Clin Oncol. 1995 Jan;13(1):19-25
7799019
World J Surg. 1987 Aug;11(4):418-25
3630186
World J Surg. 2009 Nov;33(11):2389-95
19760315
Ann Surg. 2010 Mar;251(3):417-20
20160637
N Engl J Med. 1999 Mar 25;340(12):908-14
10089184
Eur J Surg. 1993 Jun-Jul;159(6-7):361-4
8104498
Ann Surg. 1989 Nov;210(5):596-602
2818028
Arch Surg. 2000 Jul;135(7):806-10
10896374
Surg Laparosc Endosc Percutan Tech. 2009 Oct;19(5):384-7
19851265
Surg Laparosc Endosc. 1994 Apr;4(2):146-8
8180768
Surgery. 2009 Sep;146(3):469-74
19715803
Surg Endosc. 1999 Apr;13(4):351-7
10094746
J Am Coll Surg. 1997 Aug;185(2):177-84
9249086
Br J Surg. 1999 Apr;86(4):541-4
10215833
Arch Surg. 2009 Dec;144(12):1138-42
20026832
Br J Cancer. 1999 Mar;79(9-10):1522-30
10188901
Gastric Cancer. 2001;4(2):93-7
11706767
J Am Coll Surg. 1997 Apr;184(4):357-63
9100680